10th International Symposium on
Medical Information and Communication Technology (ISMICT'16)
March 20-23, 2016

Worcester Polytechnic Institute
100 Institute Rd
Worcester, MA, USA

Gregory Campbell, formerly FDA, USA
misra   Gregory Campbell has served as the Director of the Division of Biostatistics in the Office of Surveillance and Biometrics of Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for 20 years until he retired from the U.S. government in the summer of 2015. With a Ph.D. in Mathematical Statistics from Florida State University and after serving on the faculty in the Department of Statistics at Purdue University and at the National Institutes of Health, Dr. Campbell led a group at FDA of about 60 statisticians that provided support to CDRH as a whole and, in particular, the statistical reviews of FDA's pre-market device submissions that led to the approval of a large number of innovative medical devices and diagnostics. He pioneered the innovative implementation in a regulatory environment of Bayesian statistics, methods for observational studies, and adaptive designs. He is a Fellow of the American Statistical Association and a recipient of the FDA Award of Merit. Dr. Campbell served in many statistical leadership positions and has been instrumental in the recent establishment of the Medical Device and Diagnostics Section of the American Statistical Association. His research interests include the evaluation of diagnostic tests (including microarrays) as well as statistical issues in clinical trials.